Clinical Impact of Second-Generation Everolimus-Eluting Stent Compared With First-Generation Drug-Eluting Stents in Diabetes Mellitus Patients
Authors:
- Elvin KedhiEKElvin Kedhi
- Marc E. GomesMGMarc E. Gomes
- Bo LagerqvistBLBo Lagerqvist
- J. Gustav SmithJSJ. Gustav Smith
- Elmir OmerovicEOElmir Omerovic
- Stefan JamesSJStefan James
- Jan HarnekJHJan Harnek
- Göran K. OlivecronaGOGöran K. Olivecrona
- 1 November 2012
- journal article
- research article
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 5 (11) , 1141-1149
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Randomized Comparison of Everolimus-Eluting Stent Versus Sirolimus-Eluting Stent Implantation for De Novo Coronary Artery Disease in Patients With Diabetes Mellitus (ESSENCE-DIABETES)Circulation, 2011
- Differential Clinical Responses to Everolimus-Eluting and Paclitaxel-Eluting Coronary Stents in Patients With and Without Diabetes MellitusCirculation, 2011
- Everolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery DiseaseNew England Journal of Medicine, 2010
- Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trialThe Lancet, 2010
- Drug-Eluting or Bare-Metal Stenting in Patients With Diabetes MellitusCirculation, 2008
- One-Year Results of the SCORPIUS StudyJACC, 2007
- Randomized Comparison of Sirolimus-Eluting Stent Versus Standard Stent for Percutaneous Coronary Revascularization in Diabetic PatientsCirculation, 2005
- A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- Diabetes mellitus and the clinical and angiographic outcome after coronary stent placementJACC, 1998